Overview: Urine Dysmorphic RBC TestIntroduction: The Urine Dysmorphic RBC Test detects dysmorphic red blood cells in urine to diagnose kidney disease, causing blood in urine. Aligned with 2023 NKF guidelines, it uses biochemical methods for high specificity, supporting renal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected glomerular disease.
Other Names: Dysmorphic RBC Assay, Urine RBC Morphology Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Dysmorphic RBC testing began in the 1980s with glomerular disease research. Microscopy methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects dysmorphic RBCs in urine to diagnose kidney disease, guides treatment, and evaluates patients with hematuria.
Test Parameters: 1. Dysmorphic RBC Presence
Pretest Condition: No fasting required. Collect random urine. Report history of blood in urine or kidney symptoms.
Specimen: Random Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document hematuria, flank pain, or history of kidney disease. Include current medications, especially anticoagulants.
Consent: Written consent required, detailing the tests purpose, kidney disease implications, and risks of sample collection.
Procedural Considerations: Uses phase-contrast microscopy to detect dysmorphic RBCs in urine. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for glomerular disease diagnosis.
Factors Affecting Result Accuracy: Improper urine collection or contamination can affect results. Non-glomerular hematuria may reduce specificity.
Clinical Significance: Dysmorphic RBCs confirm glomerular disease, guiding renal biopsy or therapy. Normal RBCs suggest non-glomerular hematuria, requiring further evaluation.
Specialist Consultation: Consult a nephrologist for result interpretation and treatment planning.
Additional Supporting Tests: Urinalysis, renal biopsy, or proteinuria tests to confirm kidney disease diagnosis.
Test Limitations: Non-specific for glomerular disease cause; clinical correlation is needed. Sample quality affects sensitivity.
References: NKF Kidney Guidelines, 2023; American Journal of Kidney Diseases, Fogazzi GB, 2022.
